ArticleFrontiers in medicine2026
Boundary-guided VMUNet for atrophic gastritis lesion segmentation in magnifying endoscopy with narrow-band imaging.
Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Atrophic gastritis (AG) is a gastric precancerous condition, and objective delineation of lesion extent may support risk assessment, targeted biopsy, and standardized endoscopic documentation. Magnifying endoscopy with narrow-band imaging (ME-NBI) highlights mucosal and microvascular patterns, but automated segmentation remains difficult because AG lesions often show weak, gradual, and heterogeneous boundaries. Methods: We conducted a single-center retrospective study including 137 ME-NBI images of AG and 87 images of intestinal metaplasia (IM) from 25 subjects. Expert consensus masks were used as reference standards. We developed boundary-guided VMUNet (BG-VMUNet), a weak-boundary-aware segmentation framework combining a five-channel chromatic-textural input representation, visual state-space modeling, coordinate attention, and boundary-guided feature modulation. Model performance was evaluated using five-fold cross-validation and compared with representative segmentation baselines. Dice coefficient, intersection over union (IoU), precision, recall, and 95th percentile Hausdorff distance (HD95) were used to assess region overlap and boundary localization. An extended validation experiment was performed on IM segmentation. Results: In AG segmentation, BG-VMUNet achieved a Dice coefficient of 0.7228 ± 0.0504, IoU of 0.6079 ± 0.0592, precision of 0.7111 ± 0.0658, recall of 0.8266 ± 0.0265, and HD95 of 94.4665 ± 17.8695 pixels. The five-channel chromatic-textural representation and the boundary-guided architecture contributed separately: the representation provided a general, transferable benefit across backbones, whereas the boundary-guided components added further improvement on top of the representation. In a subject-level paired analysis after aggregating AG validation images within each subject, BG-VMUNet showed statistically significant improvements over the RGB VMUNet baseline in Dice, IoU, and precision after Holm correction, whereas the differences in recall and HD95 were favorable in direction but did not reach significance. In the IM extension task, BG-VMUNet showed numerically higher Dice, IoU, and precision and a lower HD95 than the baseline, with a slightly lower recall. Conclusion: BG-VMUNet provides a feasible weak-boundary-aware approach for automated AG lesion segmentation in ME-NBI images. By improving region-level delineation under challenging mucosal patterns, this framework may provide a technical basis for future quantitative assessment of gastric precancerous conditions, subject to multicenter external validation and explicit linkage to clinical endpoints. These findings are preliminary and exploratory.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.